Stanford University
Showing 801-820 of 37,072 Results
-
Amanda Almond, MSN, RN, FNP-BC
Affiliate, Central Mgmt-Misc AR
BioAmanda joined the Stanford Neurosurgery team in Santa Cruz in March of 2023. She completed a Bachelors and Masters' degree in Nursing at San Francisco State University, and post masters Nurse Practitioner Certification at SFSU. Amanda is certified through the American Association of Nurse Practitioners and her background is in Urgent Care where she has practiced the last 6 years. Currently, she practices in outpatient neurosurgery and is First Assist in surgery. Her primary interests involve neuro-oncology diseases.
-
Christopher Almond
Professor of Pediatrics (Cardiology)
On Leave from 06/08/2026 To 07/08/2026BioChristopher Almond, MD, MPH is Professor of Pediatrics in the Division of Cardiology at the Stanford University School of Medicine where he is a board-certified pediatric cardiologist at Stanford's Lucile Packard Children's Hospital in Palo Alto, CA. His clinical and research interests are focused on pediatric heart failure, mechanical circulatory support, heart transplantation, and anticoagulation. He completed his training in pediatrics, cardiology, and a senior fellowship in heart failure/transplant at Boston Children's Hospital before before appointment as Assistant Professor of Pediatrics at Harvard Medical School/Boston Children’s Hospital. Dr. Almond completed his MPH at the Harvard School of Public Health with a focus on statistics and epidemiology (study design for rare diseases) followed by a Medical Device Fellowship at the FDA in the Division of Cardiovascular Devices at CDRH. Dr. Almond moved to Stanford in 2014 where he currently serves as professor of pediatrics and directs the clinical research program within Pediatric Advanced Cardiac Therapies (PACT) Program. He also serves as Medical Director of the Children’s Heart Center Anticoagulation Management Program at Stanford (CHAMPS). Dr. Almond has a passion for collaborative research serving as PI for federally-funded multi-center clinical trials including the Berlin Heart ventricular assist device (VAD) FDA Trial that led to its FDA approval in 2011, the TEAMMATE (everolimus for heart transplant) Trial, the TROLLEY (Cardiohelp ECMO/anticoagulation RCT in heart failure) Trial, the NHLBI PumpKIN (Jarvik 2015 LVAD) Trial, and the SPOT BIAS Trial, an FDA-funded trial to understand racial/pigment bias in commercial pulse oximeters.
-
Faith Aloboudi
Ph.D. Student in Neurosciences, admitted Autumn 2024
BioI am a second-year Ph.D. Neurosciences IDP Student co-mentored by Dr. Anish Mitra and Dr. Lisa Giocomo elucidating cognitive function in mesoscale cortical networks. I’m also interested in how biopsychosocial factors, like social determinants of health, impact neuropsychiatric disorders.
-
Juan Alonso
Vance D. and Arlene C. Coffman Professor and the James and Anna Marie Spilker Chair of the Department of Aeronautics and Astronautics
BioProf. Alonso is the founder and director of the Aerospace Design Laboratory (ADL) where he specializes in the development of high-fidelity computational design methodologies to enable the creation of realizable and efficient aerospace systems. Prof. Alonso’s research involves a large number of different manned and unmanned applications including transonic, supersonic, and hypersonic aircraft, helicopters, turbomachinery, and launch and re-entry vehicles. He is the author of over 200 technical publications on the topics of computational aircraft and spacecraft design, multi-disciplinary optimization, fundamental numerical methods, and high-performance parallel computing. Prof. Alonso is keenly interested in the development of an advanced curriculum for the training of future engineers and scientists and has participated actively in course-development activities in both the Aeronautics & Astronautics Department (particularly in the development of coursework for aircraft design, sustainable aviation, and UAS design and operation) and for the Institute for Computational and Mathematical Engineering (ICME) at Stanford University. He was a member of the team that currently holds the world speed record for human powered vehicles over water. A student team led by Prof. Alonso also holds the altitude record for an unmanned electric vehicle under 5 lbs of mass.
-
Roberto Alonso-Mori
Senior Scientist, SLAC National Accelerator Laboratory
BioRoberto Alonso-Mori is a Senior Scientist and Head of the Biological Sciences (BIO) Department at the Linac Coherent Light Source (LCLS) at SLAC National Accelerator Laboratory. The BIO department supports a broad range of structural biology and biochemistry research by enabling high-impact user experiments and developing advanced capabilities for X-ray science at the frontiers of biological discovery. He also serves as the Lead for the Biochemistry and Condensed Phase Chemistry (B&CPC) Group. This group leads experiments focused on ultrafast photochemical dynamics in the condensed phase across multiple LCLS instruments using cutting-edge spectroscopy and scattering techniques. The department and group play key roles in driving scientific innovation through the LCLS Scientific Research and Development (SRD) Division, leading and contributing to the development of new experimental approaches, multimodal capabilities, and emerging applications in ultrafast bioscience and chemistry. He also serves as a Principal Investigator at the Stanford PULSE Institute, where he contributes to interdisciplinary programs advancing ultrafast science and enabling the study and control of dynamical processes in complex systems.
Dr. Roberto Alonso-Mori joined SLAC in 2010 after earning a Bachelor’s degree in Physics from the University of Oviedo (Spain), a Master of Science in Physics from the University of Grenoble (France), and a Ph.D. in Earth Sciences from the University of Camerino (Italy). His graduate research was conducted at the European Synchrotron Radiation Facility (ESRF) in Grenoble, France. He began his SLAC career as a Research Associate supporting both SSRL and LCLS, and has since held various roles leading to his current positions in departmental and scientific leadership.
